Buscar resultados de ensayos clínicos
Neuroectodermal Tumors, Primitive, Peripheral - 25 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: BEZ235 Phase II Trial in Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET) After Failure of mTOR Inhibitor Therapy. Condición: Pancreatic Neuroendocrine Tumors (pNET) Fecha: 2012-07-06 Intervenciones: Drug: BEZ235 (Stage 1) The investigational study drug used in this trial was BEZ235, which was supplied |
Active, not recruiting |
Nombre del estudio: Concurrent Carboplatin and Reduced Dose Craniospinal Radiation for Medulloblastoma and Primitive Neuroectodermal Tumor (PNET) Condición:
Fecha: 2012-02-27 Intervenciones: |
Completed |
Nombre del estudio: IMC-A12 in Treating Young Patients With Relapsed or Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor or Other Solid Tumor Condición:
|
Completed |
Nombre del estudio: High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood Condición:
|
Completed |
Nombre del estudio: Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or Rhabdomyosarcoma Condición: Sarcoma Fecha: 1999-11-01 Intervenciones:
|
Completed |
Nombre del estudio: Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer Condición:
Fecha: 1999-11-01 Intervenciones:
|
Completed |
Nombre del estudio: Study of Tumor Samples From Patients With Ewing Sarcoma Condición: Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Fecha: 2009-05-09 Intervenciones: Other: laboratory biomarker analysis Correlative studies |
Completed |
Nombre del estudio: Genetic Biomarkers in Saliva Samples From Patients With Ewing Sarcoma Condición: Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor (PNET) Fecha: 2013-06-10 Intervenciones:
|
Recruiting |
Nombre del estudio: Efficacy and Safety of Everolimus and (STZ-5FU) Given One Upfront the Other Upon Progression in Advanced pNET Condición: Pancreatic Neuroendocrine Tumours. Fecha: 2014-08-20 Intervenciones:
|
Terminated |
Nombre del estudio: Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET Condición: Islet Cell Tumor Fecha: 2011-06-14 Intervenciones:
|